NVIDIA Corporation (NVDA) is down 13.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The sell-off appears tied mainly to growing uncertainty around NVIDIA’s leadership and regulatory scrutiny, which have overshadowed otherwise strong quarterly results. Investor caution also seems to be rising around margin pressure and the company’s assumption of no China data center compute revenue in its forward outlook.
Details:
Sources:
NVIDIA Investor Relations, SEC, AP News
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- MARK A STEVENS has made 0 purchases and 21 sales selling 6,121,740 shares for an estimated $1,353,730,171.
- TIMOTHY S. TETER (EVP, General Counsel and Sec) has made 0 purchases and 6 sales selling 60,460 shares for an estimated $13,323,047.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 34,918 shares for an estimated $7,648,632.
- STEPHEN C NEAL sold 15,500 shares for an estimated $3,343,863
- JOHN DABIRI sold 625 shares for an estimated $133,750
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$NVDA Hedge Fund Activity
We have seen 3,203 institutional investors add shares of $NVDA stock to their portfolio, and 2,625 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 6,972,960,239 shares (-99.5%) from their portfolio in Q3 2026, for an estimated $1,592,484,659,382
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 160,214,733 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $36,589,840,722
- FMR LLC removed 93,243,728 shares (-9.1%) from their portfolio in Q3 2026, for an estimated $21,295,002,600
- SG AMERICAS SECURITIES, LLC added 62,298,007 shares (+inf%) to their portfolio in Q2 2026, for an estimated $12,465,208,220
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 29,501,993 shares (+15.2%) to their portfolio in Q3 2026, for an estimated $6,737,665,161
- GOLDMAN SACHS GROUP INC added 27,952,157 shares (+14.5%) to their portfolio in Q3 2026, for an estimated $6,383,713,615
- CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM removed 22,264,066 shares (-32.6%) from their portfolio in Q2 2026, for an estimated $4,454,816,965
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 25 times in the past 6 months. Of those trades, 11 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE MICHAEL A. RULLI has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/25 and 1 sale worth up to $15,000 on 10/28.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $30,000 on 10/23 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 07/17 and 2 sales worth up to $30,000 on 10/20, 08/18.
- REPRESENTATIVE PETE SESSIONS sold up to $50,000 on 10/02.
- REPRESENTATIVE CLEO FIELDS has traded it 6 times. They made 6 purchases worth up to $90,000 on 10/01, 06/26 and 0 sales.
- REPRESENTATIVE DANIEL MEUSER has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 09/25, 08/31, 05/27.
- REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 08/18.
- SENATOR SHELDON WHITEHOUSE has traded it 3 times. They made 0 purchases and 3 sales worth up to $115,000 on 08/13, 06/30.
- SENATOR CORY A. BOOKER sold up to $50,000 on 08/11.
- REPRESENTATIVE SAM LICCARDO sold up to $50,000 on 07/21.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
- REPRESENTATIVE MATTHEW VAN EPPS sold up to $15,000 on 06/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 24 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 11/18/2026
- Piper Sandler issued a "Overweight" rating on 11/18/2026
- Morgan Stanley issued a "Overweight" rating on 11/18/2026
- TD Cowen issued a "Buy" rating on 11/18/2026
- Wedbush issued a "Outperform" rating on 11/18/2026
- RBC Capital issued a "Outperform" rating on 11/18/2026
- Rosenblatt issued a "Buy" rating on 11/18/2026
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 36 analysts offer price targets for $NVDA in the last 6 months, with a median target of $230.0.
Here are some recent targets:
- C.J. Muse from Cantor Fitzgerald set a target price of $250.0 on 11/18/2026
- Matt Bryson from Wedbush set a target price of $293.0 on 11/18/2026
- Jim Kelleher from Argus Research set a target price of $220.0 on 11/18/2026
- Timothy Arcuri from UBS set a target price of $220.0 on 11/18/2026
- Harlan Sur from JP Morgan set a target price of $230.0 on 11/18/2026
- David O'Connor from Piper Sandler set a target price of $230.0 on 11/18/2026
- Kevin Cassidy from Rosenblatt set a target price of $300.0 on 11/18/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.